Biotech startup wants to give pharma giants new hope in the fight against brain disease

Scientists Brian Della Valle and Casper Hampel believe they have found a biomarker that can identify neurological diseases such as multiple sclerosis, Alzheimer's and Parkinson's disease earlier than ever before. They have now launched a company to bring their discovery to the industry.

Brian Della Valle is CEO of GLX Analytix, which he co-founded with DTU researcher Casper Hempel. Photo: GLX Analytix /PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles